absolutely. just a market darling in general!!!
one thing i disagree with though is "but if all of these products are successful are we going to be up there with the likes of GW Pharma" if ALL these products are successful medlab would be much bigger lol. Obviously depends on the definition of success i suppose. Sean estimated the market potential for nanabis in the annual report based on health economists and published literature in the 1st year of regulatory approval, $239.4m revenue and 5 years after regulatory approval, $6.73B. I guess i base success on numbers close to these in that it is just one drug. obviously revenue would be shared with third party contracts etc.
Add to My Watchlist
What is My Watchlist?